Skip to main content

Table 7 Summary statistics of participant sociodemographic characteristics, stratified by analysis inclusion

From: Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study

 

Excluded N = 145 (%)

Included N = 255 n (%)

p-value

Age (mean, SDa)

36 (9)

36 (8)

0.496b

Aboriginal and/or Torres Strait Islander

   

  No

119 (82)

215 (84)

0.561c

  Yes

26 (18)

40 (16)

 

Born outside of Australia

   

  No

125 (86)

233 (91)

0.105c

  Yes

20 (14)

22 (9)

 

Unemployed before index sentence

   

  No

14 (10)

33 (13)

0.338c

  Yes

130 (90)

222 (87)

 

Completed secondary school

   

  No

126 (87)

204 (80)

0.081c

  Yes

19 (13)

51 (20)

 

OATd at baseline interview

   

  No

81 (56)

154 (60)

0.376c

  Yes

64 (44)

101 (40)

 

Lifetime health condition

   

  No

49 (34)

85 (33)

0.925c

  Yes

96 (66)

170 (67)

 

Lifetime mental illness (N = 397)

   

  No

31 (22)

42 (16)

0.186c

  Yes

111 (78)

213 (84)

 

Main drug injected in the month prior to index imprisonment

   

  Heroin only

21 (14)

37 (15)

0.188c

  Methamphetamine only

48 (33)

94 (37)

 

  Heroin and methamphetamine

63 (43)

87 (34)

 

  No heroin or methamphetamine

13 (9)

37 (15)

 

GHQ-12e score (mean, SDa)

5 (3)

5 (3)

0.435b

  1. aStandard deviation, bindependent samples two-tailed t-test, cchi-square test, dopioid agonist treatment, eGeneral Health Questionnaire—12 Item